Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Immunity
|
November 22, 2018
Bonds Voyage! A Dissociative Model of TCR-CD3 Triggering Is Proposed
Katrina Lichauco, Mark S Lee, Michael S Kuhns
Cell Reports
|
February 2, 2018
Reciprocal TCR-CD3 and CD4 Engagement of a Nucleating pMHCII Stabilizes a Functional Receptor Macrocomplex
Caleb R Glassman, Heather L Parrish, Mark S Lee, et al.
Elife
|
July 21, 2022
Enhancing and inhibitory motifs regulate CD4 activity
Mark S Lee, Peter J Tuohy, Caleb Y Kim, et al.
Biorxiv : the Preprint Server for Biology
|
May 22, 2023
The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions
Mark S Lee, Peter J Tuohy, Caleb Y Kim, et al.
Elife
|
April 19, 2024
The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions
Mark S Lee, Peter J Tuohy, Caleb Y Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
A biomimetic five-module chimeric antigen receptor (<sup>5M</sup>CAR) designed to target and eliminate antigen-specific T cells
Shio Kobayashi, Martin A Thelin, Heather L Parrish, et al.
Clinical Pharmacology in Drug Development
|
January 8, 2024
Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm<sup>2</sup> : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis
Janet DuBois, Terry M Jones, Mark S Lee, et al.
Immunity
|
August 2, 2015
A Mechanical Switch Couples T Cell Receptor Triggering to the Cytoplasmic Juxtamembrane Regions of CD3ζζ
Mark S Lee, Caleb R Glassman, Neha R Deshpande, et al.
American Journal of Clinical Dermatology
|
October 29, 2021
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
John E Jett, Michael McLaughlin, Mark S Lee, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 31, 2022
Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis
Donald Y M Leung, Amy S Paller, Andrea L Zaenglein, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Immunity
|
November 22, 2018
Bonds Voyage! A Dissociative Model of TCR-CD3 Triggering Is Proposed
Katrina Lichauco, Mark S Lee, Michael S Kuhns
Cell Reports
|
February 2, 2018
Reciprocal TCR-CD3 and CD4 Engagement of a Nucleating pMHCII Stabilizes a Functional Receptor Macrocomplex
Caleb R Glassman, Heather L Parrish, Mark S Lee, et al.
Elife
|
July 21, 2022
Enhancing and inhibitory motifs regulate CD4 activity
Mark S Lee, Peter J Tuohy, Caleb Y Kim, et al.
Biorxiv : the Preprint Server for Biology
|
May 22, 2023
The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions
Mark S Lee, Peter J Tuohy, Caleb Y Kim, et al.
Elife
|
April 19, 2024
The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions
Mark S Lee, Peter J Tuohy, Caleb Y Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
A biomimetic five-module chimeric antigen receptor (<sup>5M</sup>CAR) designed to target and eliminate antigen-specific T cells
Shio Kobayashi, Martin A Thelin, Heather L Parrish, et al.
Clinical Pharmacology in Drug Development
|
January 8, 2024
Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm<sup>2</sup> : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis
Janet DuBois, Terry M Jones, Mark S Lee, et al.
Immunity
|
August 2, 2015
A Mechanical Switch Couples T Cell Receptor Triggering to the Cytoplasmic Juxtamembrane Regions of CD3ζζ
Mark S Lee, Caleb R Glassman, Neha R Deshpande, et al.
American Journal of Clinical Dermatology
|
October 29, 2021
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
John E Jett, Michael McLaughlin, Mark S Lee, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 31, 2022
Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis
Donald Y M Leung, Amy S Paller, Andrea L Zaenglein, et al.
Page
of 2